0001127602-24-009540.txt : 20240311
0001127602-24-009540.hdr.sgml : 20240311
20240311205954
ACCESSION NUMBER: 0001127602-24-009540
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240310
FILED AS OF DATE: 20240311
DATE AS OF CHANGE: 20240311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dickinson Andrew D
CENTRAL INDEX KEY: 0001310204
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19731
FILM NUMBER: 24739995
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DRIVE
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GILEAD SCIENCES, INC.
CENTRAL INDEX KEY: 0000882095
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 943047598
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6505743000
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
FORMER COMPANY:
FORMER CONFORMED NAME: GILEAD SCIENCES INC
DATE OF NAME CHANGE: 19930328
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-03-10
0000882095
GILEAD SCIENCES, INC.
GILD
0001310204
Dickinson Andrew D
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE
FOSTER CITY
CA
94404
1
Chief Financial Officer
0
Common Stock
2024-03-10
4
M
0
3025
A
132781
D
Common Stock
2024-03-10
4
M
0
6707
A
139488
D
Common Stock
2024-03-10
4
F
0
4505
75.12
D
134983
D
Restricted Stock Unit
2024-03-10
4
M
0
3025
D
Common Stock
3025
35040
D
Restricted Stock Unit
2024-03-10
4
M
0
6707
D
Common Stock
6707
28333
D
Non-qualified Stock Option (Right to Buy)
75.12
2024-03-10
4
A
0
87970
0
A
2034-03-10
Common Stock
87970
87970
D
Restricted Stock Unit
2024-03-10
4
A
0
17305
A
Common Stock
17305
46407
D
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan.
The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.
The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
The options have a four year vesting schedule. 25% vest on the first anniversary date of the date grant. The balance will vest 6.25% quarterly thereafter until fully vested.
/s/ Edward S. Son by Power of Attorney for Andrew D. Dickinson
2024-03-11